Médecine de l'alpinisme et des sports de montagne, 2006. ,
Modifications physiologiques et pathologiques en haute altitude, Présentation. Mars, 2008. ,
Petit manuel de médecine de montagne de l'ampoule à l'oedème pulmonaire et de la randonnée à l'expé himalayenne. Glénat, 2007. ,
Physiology of high-altitude acclimatization, Resonance, vol.253, issue.1???2, pp.538-586 ,
DOI : 10.1007/s12045-014-0057-3
Médicaments cardiovasculaires : peut-on prédire leur effet en altitude? Cardio & Sport, pp.14-23, 2005. ,
High-altitude illnesses: Physiology, risk factors, prevention, and treatment, Rambam Maimonides Medical Journal, vol.2, issue.1, 2011. ,
DOI : 10.5041/RMMJ.10022
Aborder l'altitude en toute sécutiré -prévention du MAM et des oedèmes d'altitude. Revue Médecine Générale, Juin, issue.284, 2011. ,
-063- 10) Disponible sur internet, Poumon et altitude. Elsevier Masson, issue.6, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00265263
Le cerveau à très haute altitude, Cerveau&Psycho, issue.40, pp.52-59, 2010. ,
Acute mountain sickness in disability and adaptive sports: Preliminary data, The Journal of Rehabilitation Research and Development, vol.45, issue.4, pp.479-88, 2008. ,
DOI : 10.1682/JRRD.2007.08.0136
Mise au point : aspects neurologiques de la pathologie d'altitude, pp.235-276, 2003. ,
Les maladies aiguës liées à la haute altitude. Recommandations pour leur prise en charge et avancées expérimentales récentes : Médecine des voyages, Médecine & Hygiène, vol.61, pp.1007-1020, 2003. ,
Pathologies d'altitude (dont gelures) Médecine Urgence, p.30, 2010. ,
DOI : 10.1016/s1959-5182(10)43737-x
Physiopathologie de l'hypoxie d'altitude, Médecine & Hygiène, issue.54, pp.1062-1068, 1996. ,
Maladies liées à l'altitude et consultation de médecine de montagne, Forum Medical Suisse, vol.12, issue.41, pp.789-93, 2012. ,
Oedèmes patologiques induits par l'hypoxie d'altitude, Réanimation, issue.10, pp.103-114, 2001. ,
Mal aigu des montagnes et oedème cérébral de haute montagne, La Revue du Praticien. Janvier, vol.63, issue.1, pp.18-26, 2013. ,
High-altitude illness, Emergency Medicine Clinics of North America, vol.22, issue.2, pp.329-55, 2004. ,
DOI : 10.1016/j.emc.2004.02.001
Guide pratique des médicaments. Paris: Maloine, 2013. ,
Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude, Sleep, vol.30, issue.11, p.1527, 2007. ,
Which Medications Are Safe and Effective for Improving Sleep at High Altitude ? High Altitude, Medicine & Biology. Septembre, vol.9, issue.3, pp.195-203, 2008. ,
Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness, Journal of Applied Physiology, vol.102, issue.4, pp.1313-1335, 2006. ,
DOI : 10.1152/japplphysiol.01572.2005
Acute Mountain Sickness: Pathophysiology, Prevention, and Treatment, Progress in Cardiovascular Diseases, vol.52, issue.6, pp.467-84, 2010. ,
DOI : 10.1016/j.pcad.2010.02.003
Altitude illness: risk factors, prevention, presentation, and treatment, American Family Physician. Novembre, vol.82, issue.9, pp.1103-1113, 2010. ,
Acute Mountain Sickness, High Altitude Cerebral Edema and High Altitude Pulmonary Edema. School of Physician Assistant Studies, 2008. ,
Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness, Wilderness & Environmental Medicine, vol.21, issue.2, pp.146-55, 2010. ,
DOI : 10.1016/j.wem.2010.03.002
Patterns and correlates of benzodiazepine use in the French general population, European Journal of Clinical Pharmacology, vol.17, issue.11, pp.523-532, 2004. ,
DOI : 10.1007/s00228-004-0808-2
Disponible sur : http://compendium.ch/mpro/ mnr, 15556. ,
Marchal university school of medecine, pp.1-5, 2007. ,
Acute mountain sickness prophylaxis : knowledge, attitudes & behaviours in the Everest region of Nepal. Travel Medicine & Infectious Disease, Novembre, vol.8, issue.6, pp.395-400, 2010. ,
Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro, High Altitude Medicine & Biology, vol.11, issue.3, pp.217-239, 2010. ,
DOI : 10.1089/ham.2010.1003
Determination of acetazolamide in human urine samples by reversed-phase high-performance liquid chromatography in the presence of xanthines, Journal of Chromatography B: Biomedical Sciences and Applications, vol.582, issue.1-2, pp.181-188, 1992. ,
DOI : 10.1016/0378-4347(92)80317-J
Application of column-switching techniques to the determination of medium polarity drugs: determination of acetazolamide in urine, Journal of Chromatography B: Biomedical Sciences and Applications, vol.654, issue.1, pp.85-90, 1994. ,
DOI : 10.1016/0378-4347(94)00005-0
Biochimie clinique conforme au programme du CNCI. Paris : Vernazobres-Grego, 2011. ,
The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis, British Journal of Pharmacology, vol.72, issue.1, pp.1-16, 2010. ,
DOI : 10.1111/j.1476-5381.2010.00789.x
Evidence on ergogenic action of Glucocorticoids as a doping agent risk. Physician & Sportsmedicine, Octobre, vol.38, issue.3, pp.121-128, 2010. ,
Manifestations cardiovasculaires des substances r??cr??atives??: alcool, coca??ne, amph??tamines, ecstasy, h??ro??ne et cannabis, R??animation, vol.14, issue.3, pp.186-95, 2005. ,
DOI : 10.1016/j.reaurg.2005.02.009
Ephedrine, Pseudoephedrine, and Amphetamine Prevalence in College Hockey Players, The Physician and Sportsmedicine, vol.24, issue.2, pp.30-34, 2004. ,
DOI : 10.3109/10550499808995637
Testosterone and doping control, British Journal of Sports Medicine, vol.40, issue.Supplement 1, pp.40-61, 2006. ,
DOI : 10.1136/bjsm.2006.027482
Evaluation of Testosterone/Epitestosterone Ratio Influential Factors as Determined in Doping Analysis, Journal of Analytical Toxicology, vol.24, issue.2, pp.102-117, 2000. ,
DOI : 10.1093/jat/24.2.102
Indirect androgen doping by oestrogen blockade in sports, British Journal of Pharmacology, vol.52, issue.Suppl 1, pp.598-605, 2008. ,
DOI : 10.1038/bjp.2008.150
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers. Drug and Alcohol Dependence, Décembre, vol.98, issue.3, pp.191-202, 2008. ,
Urinary Elimination of 11-Nor-9-Carboxy-??9-tetrahydrocannnabinol in Cannabis Users During Continuously Monitored Abstinence, Journal of Analytical Toxicology, vol.32, issue.8, pp.562-569, 2008. ,
DOI : 10.1093/jat/32.8.562
Urinary Excretion Profiles of 11-Nor-9-Carboxy-??9-Tetrahydrocannabinol in Humans after Single Smoked Doses of Marijuana, Journal of Analytical Toxicology, vol.20, issue.6, pp.441-52, 1996. ,
DOI : 10.1093/jat/20.6.441
Residual Effects of Hypnotics, CNS Drugs, vol.19, issue.1, 2004. ,
DOI : 10.2165/00023210-200418050-00003
Abuse and misuse of antidepressants, Substance Abuse and Rehabilitation, vol.107, 2014. ,
DOI : 10.2147/SAR.S37917
Clinical evaluation of zaleplon in the treatment of insomnia, Journal of Nature and Science of Sleep. Février, vol.2010, issue.2, pp.115-141, 2010. ,
Prevention of high altitude illness. Travel Medicine and Infectious Disease, Janvier, vol.12, issue.1, pp.29-39, 2014. ,
Questionnaire du Score Disponible sur : http://theses.ulb.ac ,